ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress.

Yuan D, Fang Y, Chen W, Jiang K, Zhu G, Wang W, Zhang W, You G, Jia Z, Zhu J

Open source

DOI
10.1155/2022/3611540
Published
2022
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/3611540,
  title = {ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress.},
  author = {Yuan D and Fang Y and Chen W and Jiang K and Zhu G and Wang W and Zhang W and You G and Jia Z and Zhu J},
  year = {2022},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/2022/3611540},
  url = {https://doi.org/10.1155/2022/3611540}
}

RIS

TY  - JOUR
TI  - ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress.
AU  - Yuan D
AU  - Fang Y
AU  - Chen W
AU  - Jiang K
AU  - Zhu G
AU  - Wang W
AU  - Zhang W
AU  - You G
AU  - Jia Z
AU  - Zhu J
PY  - 2022
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/2022/3611540
UR  - https://doi.org/10.1155/2022/3611540
ER  - 

APA

D, Y., Y, F., W, C., K, J., G, Z., W, W., W, Z., G, Y., Z, J., & J, Z. (2022). ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/2022/3611540

Source records